Patents by Inventor Klaus Eschmann

Klaus Eschmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10293014
    Abstract: Disclosed is a composition which comprises a combination of Aronia extract in an amount of at least about 10 ?g/mg and seleniumin in an amount from about 0.0001 ?g/mg to about 2.0 ?g/mg. The composition may further comprise zinc as additional micronutrient. The composition may be formulated as a pharmaceutical or a nutraceutical composition.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: May 21, 2019
    Assignee: Ursapharm Arzneimittel GmbH
    Inventors: Klaus Eschmann, Josef Beuth
  • Publication number: 20150132418
    Abstract: Disclosed is a composition which comprises a combination of Aronia extract in an amount of at least about 10 ?g/mg and seleniumin in an amount from about 0.0001 ?g/mg to about 2.0 ?g/mg. The composition may further comprise zinc as additional micronutrient. The composition may be formulated as a pharmaceutical or a nutraceutical composition.
    Type: Application
    Filed: January 20, 2015
    Publication date: May 14, 2015
    Inventors: Klaus ESCHMANN, Josef BEUTH
  • Patent number: 8409840
    Abstract: The present invention pertains in general to Bromelain and particularly to the different active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed cysteine proteases, which are found in Bromelain. It has been found that the method for expression of the recombinant proteins is superior to the purification from Bromelain itself.
    Type: Grant
    Filed: August 8, 2008
    Date of Patent: April 2, 2013
    Assignee: Ursapharm Arzneimittel GmbH
    Inventors: Rolf Müller, Nora Luniak, Klaus Eschmann
  • Publication number: 20120148683
    Abstract: It pertains to a composition which comprises a combination of Aronia extract in an amount of at least about 10 ?g/mg and seleniumin in an amount from about 0.0001 ?g/mg to about 2.0 ?g/mg. The composition may further comprise zinc as additional micronutrient. The composition may be formulated as a pharmaceutical or a nutraceutical composition.
    Type: Application
    Filed: May 6, 2010
    Publication date: June 14, 2012
    Applicant: URSAPHARM ARZNEIMITTEL GMBH
    Inventors: Klaus Eschmann, Josef Beuth
  • Publication number: 20110200541
    Abstract: The present invention pertains in general to Bromelain and particularly to the active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed Bromelain inhibitor precursor and Bromelain inhibitors, which are found in Bromelain. It has been found that the recombinant expressed inhibitors have superior effects in terms of treatment of disorders and conditions than Bromelain or its protein fractions from plant extracts.
    Type: Application
    Filed: July 27, 2009
    Publication date: August 18, 2011
    Applicant: Ursapharm Arzneimittel GmbH
    Inventors: Rolf Müller, Nora Luniak, Klaus Eschmann
  • Publication number: 20100272659
    Abstract: The present invention pertains in general to Bromelain and particularly to the different active compounds contained in this complex mixture of proteins. The present invention provides recombinant expressed cysteine proteases, which are found in Bromelain. It has been found that the method for expression of the recombinant proteins is superior to the purification from Bromelain itself.
    Type: Application
    Filed: August 8, 2008
    Publication date: October 28, 2010
    Applicant: URSAPHARM ARZNEIMITTEL GMBH
    Inventors: Rolf Müller, Nora Luniak, Klaus Eschmann
  • Patent number: 7731958
    Abstract: The present application pertains to the use of bromelain preparing a medicament for increasing the IL-(8) level in an individual so as to reduce or prevent inflammation in said individual and as an adjuvant therapy during wound healing processes.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: June 8, 2010
    Assignee: Ursapharm Arzneimittel GmbH & Co. KG
    Inventors: Rainer Maurer, Klaus Eschmann
  • Patent number: 6803038
    Abstract: The present invention relates to the use of bromelaine proteases for inhibiting blood coagulation, especially for stimulating the production of plasmin, for inhibiting the production of fibrin and for inhibiting the adhesion of human thrombocytes on endothelilum cells. Especially the basic proteases isolable from raw bromelaine have proved to be particularly suitable proteases.
    Type: Grant
    Filed: July 25, 2001
    Date of Patent: October 12, 2004
    Assignee: Ursapharm Arzneimittel GmbH
    Inventors: Rainer Maurer, Klaus Eckert, Edyta Grabowska, Klaus Eschmann
  • Publication number: 20040043018
    Abstract: The present application pertains to the use of bromelain preparing a medicament for increasing the IL-(8) level in an individual so as to reduce or prevent inflammation in said individual and as an adjuvant therapy during wound healing processes.
    Type: Application
    Filed: April 24, 2003
    Publication date: March 4, 2004
    Inventors: Rainer Maurer, Klaus Eschmann